Regorafenib to be fast-tracked by US authorities Posted on 22nd June 201128th February 2019 The assessment of Bayer HealthCare’s investigational drug regorafenib for the treatment of stomach tumoursis to be fast-tracked by US authorities for the treatment of stomach tumours Click here to read the report. Posted in GIST News.